Based on the history and reports, this appears more consistent with chronic
liver disease (CLD) with portal hypertension, associated gallstone disease (calculous cholecystitis), and recurrent episodes of obstructive jaundice/cholangitis. The MRCP does not show dilatation of the bile ducts or a CBD stone at present, so the jaundice may not be due to persistent biliary obstruction alone.
Diabetes-related metabolic liver disease (MASLD/NASH), previous infections, viral hepatitis, autoimmune liver disease, or other chronic liver disorders should also be evaluated as possible underlying causes.
Gallbladder removal should not be decided solely on the basis of gallstones. Because there is evidence of portal hypertension, splenomegaly, and collateral vessels, cholecystectomy carries a higher surgical risk and should be planned only after evaluation by a hepatologist and an experienced hepatobiliary surgeon.
Next Steps
* Urgent consultation with a hepatologist/gastroenterologist.
* Complete CLD work-up: viral hepatitis markers (HBV/HCV), autoimmune
liver profile, iron studies, ceruloplasmin (if indicated), and metabolic evaluation.
* Triple-phase CT liver (as advised in the MRI report) and serum AFP to characterize the liver lesion.
* Upper GI endoscopy to screen for esophageal varices because of portal hypertension.
* Monitor
liver function tests, INR/PT, CBC, and renal function.
* If fever, jaundice, or abdominal pain persists, hospital admission is warranted to rule out acute cholangitis, which may require IV antibiotics and urgent biliary intervention.
Health Tips
Although the situation is serious, it is treatable. The priority is to identify the underlying cause of the chronic
liver disease and stabilize liver function before considering gallbladder surgery.